ArticleClinical transplantation and research2026
KoreaN cohort study for Outcomes in patients With Kidney Transplantation (KNOW-KT): a prospective observational cohort study focusing on graft outcomes and posttransplant complications.
Article in Clinical transplantation and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The KoreaN cohort study for Outcome in patients With Kidney Transplantation (KNOW-KT) is a prospective, multicenter observational cohort designed to provide detailed information on the natural course of kidney transplantation (KT) and to identify risk factors for posttransplant complications. We aimed to describe graft outcomes and long-term posttransplant complications from the KNOW-KT study. Methods: KNOW-KT enrolled 1,115 transplant recipients between 2012 and 2016 and followed them for up to 11 years. Data and biological samples were collected from both transplant recipients and donors at baseline and during annual follow-up visits. Epidemiological factors, laboratory data, allograft outcomes, and patient outcomes, including posttransplant complications, comorbidities, and mortality, were analyzed. Results: A total of 1,080 kidney transplants were registered (86.9% from living donors) with a mean recipient age of 45.8±11.6 years. ABO- and human leukocyte antigen-incompatible transplants accounted for 17.4% and 8.1% of cases, respectively, and 26.7% of recipients underwent pretransplant desensitization. The overall 1-, 5-, and 10-year graft survival rates were 98.5%, 95.0%, and 91.9%, respectively. During a median follow-up period of 9.8 years, graft failure occurred in 7.6% of recipients, while biopsy-proven acute rejection episodes were observed in 19.4%. The cumulative incidence of new-onset malignancy and infection was 7.3 per 1,000 person-years and 41.2 per 1,000 person-years, respectively. Conclusions: The KNOW-KT study characterizes the epidemiology of Korean kidney transplant recipients and provides robust, reliable information on long-term posttransplant outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.